Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration

[Display omitted] The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2016-02, Vol.498 (1-2), p.142-152
Hauptverfasser: Arbelaez-Camargo, Diana, Suñé-Negre, Josep Maria, Roig-Carreras, Manel, García-Montoya, Encarna, Pérez-Lozano, Pilar, Miñarro-Carmona, Montserrat, Ticó-Grau, Josep Ramon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 152
container_issue 1-2
container_start_page 142
container_title International journal of pharmaceutics
container_volume 498
creator Arbelaez-Camargo, Diana
Suñé-Negre, Josep Maria
Roig-Carreras, Manel
García-Montoya, Encarna
Pérez-Lozano, Pilar
Miñarro-Carmona, Montserrat
Ticó-Grau, Josep Ramon
description [Display omitted] The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.
doi_str_mv 10.1016/j.ijpharm.2015.12.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1760930540</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517315304130</els_id><sourcerecordid>1760930540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</originalsourceid><addsrcrecordid>eNqFUctu1DAUtRCIDoVPAHnJJsGPxM6sEKoKRaoEC1hbjn098ciJg52MWr6Mz8NDBrasrnTvedkHodeU1JRQ8e5Y--M86DTWjNC2pqwmlD1BO9pJXvFGiqdoR7jsqpZKfoVe5HwkhAhG-XN0xYToWsnEDv36msDFNK5BLz5OWE8WmyKrzQLJ_9yW0WGNg7fRaD8BHh5timYIMXkLfxgWHvQIy6BzLPccrV9HPA8xl4QL4GWANMYqwQlS9n3YSL2P2g6Q_QlwiNOhKp5-OuADBFwiYT8tSc8lxVJEdcDajn7yuSzPoV6iZ06HDK8u8xp9_3j77eauuv_y6fPNh_vK8D1dKkda21rHOib3jAvHpOSUcudI0ztBqISWaCGkaBynet903AEXkoHsre6F4Nfo7aY7p_hjhbyo0WcDIegJ4poVlYLsOWkbUqDtBjUp5lz-Vc3Jjzo9KkrUuTR1VJfS1Lk0RZkqpRXem4vF2o9g_7H-tlQA7zcAlIeePCSVjYfJgPUJzKJs9P-x-A3Q37EY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760930540</pqid></control><display><type>article</type><title>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Arbelaez-Camargo, Diana ; Suñé-Negre, Josep Maria ; Roig-Carreras, Manel ; García-Montoya, Encarna ; Pérez-Lozano, Pilar ; Miñarro-Carmona, Montserrat ; Ticó-Grau, Josep Ramon</creator><creatorcontrib>Arbelaez-Camargo, Diana ; Suñé-Negre, Josep Maria ; Roig-Carreras, Manel ; García-Montoya, Encarna ; Pérez-Lozano, Pilar ; Miñarro-Carmona, Montserrat ; Ticó-Grau, Josep Ramon</creatorcontrib><description>[Display omitted] The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2015.12.012</identifier><identifier>PMID: 26685726</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adhesiveness ; Adhesives - chemistry ; Bioadhesive ; Chemistry, Pharmaceutical ; Controlled release ; Delayed-Action Preparations - chemistry ; Dexamethasone ; Dexamethasone - analogs &amp; derivatives ; Dexamethasone - chemistry ; Gels ; Injections, Intraperitoneal ; Intraperitoneal administration ; Lidocaine ; Lidocaine - chemistry ; Poloxamer - chemistry ; Poloxamer 407 ; Temperature ; Thermoreversible gel ; Viscosity</subject><ispartof>International journal of pharmaceutics, 2016-02, Vol.498 (1-2), p.142-152</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</citedby><cites>FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</cites><orcidid>0000-0001-6245-5666</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378517315304130$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26685726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arbelaez-Camargo, Diana</creatorcontrib><creatorcontrib>Suñé-Negre, Josep Maria</creatorcontrib><creatorcontrib>Roig-Carreras, Manel</creatorcontrib><creatorcontrib>García-Montoya, Encarna</creatorcontrib><creatorcontrib>Pérez-Lozano, Pilar</creatorcontrib><creatorcontrib>Miñarro-Carmona, Montserrat</creatorcontrib><creatorcontrib>Ticó-Grau, Josep Ramon</creatorcontrib><title>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.</description><subject>Adhesiveness</subject><subject>Adhesives - chemistry</subject><subject>Bioadhesive</subject><subject>Chemistry, Pharmaceutical</subject><subject>Controlled release</subject><subject>Delayed-Action Preparations - chemistry</subject><subject>Dexamethasone</subject><subject>Dexamethasone - analogs &amp; derivatives</subject><subject>Dexamethasone - chemistry</subject><subject>Gels</subject><subject>Injections, Intraperitoneal</subject><subject>Intraperitoneal administration</subject><subject>Lidocaine</subject><subject>Lidocaine - chemistry</subject><subject>Poloxamer - chemistry</subject><subject>Poloxamer 407</subject><subject>Temperature</subject><subject>Thermoreversible gel</subject><subject>Viscosity</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUctu1DAUtRCIDoVPAHnJJsGPxM6sEKoKRaoEC1hbjn098ciJg52MWr6Mz8NDBrasrnTvedkHodeU1JRQ8e5Y--M86DTWjNC2pqwmlD1BO9pJXvFGiqdoR7jsqpZKfoVe5HwkhAhG-XN0xYToWsnEDv36msDFNK5BLz5OWE8WmyKrzQLJ_9yW0WGNg7fRaD8BHh5timYIMXkLfxgWHvQIy6BzLPccrV9HPA8xl4QL4GWANMYqwQlS9n3YSL2P2g6Q_QlwiNOhKp5-OuADBFwiYT8tSc8lxVJEdcDajn7yuSzPoV6iZ06HDK8u8xp9_3j77eauuv_y6fPNh_vK8D1dKkda21rHOib3jAvHpOSUcudI0ztBqISWaCGkaBynet903AEXkoHsre6F4Nfo7aY7p_hjhbyo0WcDIegJ4poVlYLsOWkbUqDtBjUp5lz-Vc3Jjzo9KkrUuTR1VJfS1Lk0RZkqpRXem4vF2o9g_7H-tlQA7zcAlIeePCSVjYfJgPUJzKJs9P-x-A3Q37EY</recordid><startdate>20160210</startdate><enddate>20160210</enddate><creator>Arbelaez-Camargo, Diana</creator><creator>Suñé-Negre, Josep Maria</creator><creator>Roig-Carreras, Manel</creator><creator>García-Montoya, Encarna</creator><creator>Pérez-Lozano, Pilar</creator><creator>Miñarro-Carmona, Montserrat</creator><creator>Ticó-Grau, Josep Ramon</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6245-5666</orcidid></search><sort><creationdate>20160210</creationdate><title>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</title><author>Arbelaez-Camargo, Diana ; Suñé-Negre, Josep Maria ; Roig-Carreras, Manel ; García-Montoya, Encarna ; Pérez-Lozano, Pilar ; Miñarro-Carmona, Montserrat ; Ticó-Grau, Josep Ramon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adhesiveness</topic><topic>Adhesives - chemistry</topic><topic>Bioadhesive</topic><topic>Chemistry, Pharmaceutical</topic><topic>Controlled release</topic><topic>Delayed-Action Preparations - chemistry</topic><topic>Dexamethasone</topic><topic>Dexamethasone - analogs &amp; derivatives</topic><topic>Dexamethasone - chemistry</topic><topic>Gels</topic><topic>Injections, Intraperitoneal</topic><topic>Intraperitoneal administration</topic><topic>Lidocaine</topic><topic>Lidocaine - chemistry</topic><topic>Poloxamer - chemistry</topic><topic>Poloxamer 407</topic><topic>Temperature</topic><topic>Thermoreversible gel</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arbelaez-Camargo, Diana</creatorcontrib><creatorcontrib>Suñé-Negre, Josep Maria</creatorcontrib><creatorcontrib>Roig-Carreras, Manel</creatorcontrib><creatorcontrib>García-Montoya, Encarna</creatorcontrib><creatorcontrib>Pérez-Lozano, Pilar</creatorcontrib><creatorcontrib>Miñarro-Carmona, Montserrat</creatorcontrib><creatorcontrib>Ticó-Grau, Josep Ramon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arbelaez-Camargo, Diana</au><au>Suñé-Negre, Josep Maria</au><au>Roig-Carreras, Manel</au><au>García-Montoya, Encarna</au><au>Pérez-Lozano, Pilar</au><au>Miñarro-Carmona, Montserrat</au><au>Ticó-Grau, Josep Ramon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2016-02-10</date><risdate>2016</risdate><volume>498</volume><issue>1-2</issue><spage>142</spage><epage>152</epage><pages>142-152</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26685726</pmid><doi>10.1016/j.ijpharm.2015.12.012</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6245-5666</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2016-02, Vol.498 (1-2), p.142-152
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_1760930540
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adhesiveness
Adhesives - chemistry
Bioadhesive
Chemistry, Pharmaceutical
Controlled release
Delayed-Action Preparations - chemistry
Dexamethasone
Dexamethasone - analogs & derivatives
Dexamethasone - chemistry
Gels
Injections, Intraperitoneal
Intraperitoneal administration
Lidocaine
Lidocaine - chemistry
Poloxamer - chemistry
Poloxamer 407
Temperature
Thermoreversible gel
Viscosity
title Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T08%3A57%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preformulation%20and%20characterization%20of%20a%20lidocaine%20hydrochloride%20and%20dexamethasone%20sodium%20phosphate%20thermo-reversible%20and%20bioadhesive%20long-acting%20gel%20for%20intraperitoneal%20administration&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Arbelaez-Camargo,%20Diana&rft.date=2016-02-10&rft.volume=498&rft.issue=1-2&rft.spage=142&rft.epage=152&rft.pages=142-152&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2015.12.012&rft_dat=%3Cproquest_cross%3E1760930540%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760930540&rft_id=info:pmid/26685726&rft_els_id=S0378517315304130&rfr_iscdi=true